Enantiospecific effects of ketoconazole on aryl hydrocarbon receptor

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Novotna, Aneta ^a   Korhonova, Martina ^a   Bartonkova, Iveta ^a   Soshilov, Anatoly A ^b   Denison, Michael S ^b   Bogdanova, Katerina ^a   Kolar, Milan ^a   Bednar, Petr ^a   Dvorak, Zdenek ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; FLUCONAZOLE; KETOCONAZOLE; POSACONAZOLE; TYROSINE AMINOTRANSFERASE; VORICONAZOLE; ANTIFUNGAL AGENT; MESSENGER RNA;

ADULT; ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; DRUG DETERMINATION; ENANTIOMER; ENANTIOSELECTIVITY; ENZYME ACTIVATION; FEMALE; FUNGAL STRAIN; GEL MOBILITY SHIFT ASSAY; GUINEA PIG; HUMAN; HUMAN CELL; LIVER CELL; MALE; NONHUMAN; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RECEPTOR BINDING ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; AGED; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; HEPG2 CELL LINE; METABOLISM; MIDDLE AGED; MOUSE; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

AGED; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; FEMALE; GUINEA PIGS; HEP G2 CELLS; HEPATOCYTES; HUMANS; KETOCONAZOLE; MALE; MICE; MIDDLE AGED; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC;

EID: 84904395409     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101832     Document Type: Article

References (27)

1. Sonino N, Boscaro M, Paoletta A, Mantero F, Ziliotto D (1991) Ketoconazole treatment in Cushing's syndrome: experience in 34 patients. Clin Endocrinol (Oxf) 35: 347-352.
2. Pont A, Graybill JR, Craven PC, Galgiani JN, Dismukes WE, et al. (1984) Highdose ketoconazole therapy and adrenal and testicular function in humans. Arch Intern Med 144: 2150-2153. (Pubitemid 15215501)
3. Stricker BH, Blok AP, Bronkhorst FB, Van Parys GE, Desmet VJ (1986) Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases. J Hepatol 3: 399-406. (Pubitemid 17227491)
4. Bercoff E, Bernuau J, Degott C, Kalis B, Lemaire A, et al. (1985) Ketoconazoleinduced fulminant hepatitis. Gut 26: 636-638.
5. Benson GD, Anderson PK, Combes B, Ishak KG (1988) Prolonged jaundice following ketoconazole-induced hepatic injury. Dig Dis Sci 33: 240-246. (Pubitemid 18054689)
6. Daneshmend TK, Warnock DW (1988) Clinical pharmacokinetics of ketoconazole. Clin Pharmacokinet 14: 13-34.
7. Rotstein DM, Kertesz DJ, Walker KA, Swinney DC (1992) Stereoisomers of ketoconazole: preparation and biological activity. J Med Chem 35: 2818-2825.
8. Dilmaghanian S, Gerber JG, Filler SG, Sanchez A, Gal J (2004) Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4) by ketoconazole: Testosterone and methadone as substrates. Chirality 16: 79-85. (Pubitemid 38134070)
9. Allqvist A, Miura J, Bertilsson L, Mirghani RA (2007) Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers. Eur J Clin Pharmacol 63: 173-179. (Pubitemid 46147059)
10. Boxenbaum H (1999) Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in general. J Pharm Pharm Sci 2: 47-52.
11. Stresser DM, Blanchard AP, Turner SD, Erve JC, Dandeneau AA, et al. (2000) Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metab Dispos 28: 1440-1448.
12. Duret C, Daujat-Chavanieu M, Pascussi JM, Pichard-Garcia L, Balaguer P, et al. (2006) Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor. Mol Pharmacol 70: 329-339.
13. Dvorak Z (2011) Drug-drug interactions by azole antifungals: Beyond a dogma of CYP3A4 enzyme activity inhibition. Toxicol Lett 202: 129-132.
14. Korashy HM, Shayeganpour A, Brocks DR, El-Kadi AO (2007) Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines. Toxicol Sci 97: 32-43. (Pubitemid 47072153)
15. Jack SM, Dobbins M, Sword W, Novotna G, Brooks S, et al. (2011) Evidence-informed decision-making by professionals working in addiction agencies serving women: a descriptive qualitative study. Subst Abuse Treat Prev Policy 6: 29.
16. Vrzal R, Daujat-Chavanieu M, Pascussi JM, Ulrichova J, Maurel P, et al. (2008) Microtubules-interfering agents restrict aryl hydrocarbon receptor-mediated CYP1A2 induction in primary cultures of human hepatocytes via c-jun-Nterminal kinase and glucocorticoid receptor. Eur J Pharmacol 581: 244-254.
17. Novotna A, Pavek P, Dvorak Z (2011) Novel stably transfected gene reporter human hepatoma cell line for assessment of aryl hydrocarbon receptor transcriptional activity: construction and characterization. Environ Sci Technol 45: 10133-10139.
18. Novotna A, Pavek P, Dvorak Z (2012) Construction and characterization of a reporter gene cell line for assessment of human glucocorticoid receptor activation. Eur J Pharm Sci 47: 842-847.
19. Denison MS, Rogers JM, Rushing SR, Jones CL, Tetangco SC, et al. (2002) Analysis of the aryl hydrocarbon receptor (AhR) signal transduction pathway. Curr Protoc Toxicol Chapter 4: Unit4 8.
20. Castro-Puyana M, Garcia-Ruiz C, Cifuentes A, Crego AL, Marina ML (2006) Identification and quantitation of cis-ketoconazole impurity by capillary zone electrophoresis-mass spectrometry. J Chromatogr A 1114: 170-177.
21. Monostory K, Dvorak Z (2011) Steroid regulation of drug-metabolizing cytochromes P450. Curr Drug Metab 12: 154-172.
22. Svecova L, Vrzal R, Burysek L, Anzenbacherova E, Cerveny L, et al. (2008) Azole antimycotics differentially affect rifampicin-induced pregnane X receptormediated CYP3A4 gene expression. Drug Metab Dispos 36: 339-348. (Pubitemid 351185746)
23. Hasselberg L, Grosvik BE, Goksoyr A, Celander MC (2005) Interactions between xenoestrogens and ketoconazole on hepatic CYP1A and CYP3A, in juvenile Atlantic cod (Gadus morhua). Comp Hepatol 4: 2.
24. Babin M, Casado S, Chana A, Herradon B, Segner H, et al. (2005) Cytochrome P4501A induction caused by the imidazole derivative Prochloraz in a rainbow trout cell line. Toxicol In Vitro 19: 899-902. (Pubitemid 41563224)
25. Sun G, Thai SF, Tully DB, Lambert GR, Goetz AK, et al. (2005) Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver. Toxicol Lett 155: 277-287. (Pubitemid 39643213)
26. Schwartz SL, Rendell M, Ahmann AJ, Thomas A, Arauz-Pacheco CJ, et al. (2008) Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus. Clin Ther 30: 1081- 1088.
27. Arakaki R, Welles B (2010) Ketoconazole enantiomer for the treatment of diabetes mellitus. Expert Opin Investig Drugs 19: 185-194.